News & Events
News & Events

News Releases

June 7, 2017

ProSciento and OWL Metabolomics Form Strategic Collaboration Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment Read More »

May 30, 2017

ProSciento Appoints Dr. Kelvin Logan, Former Executive at INC Research and Quintiles, to its Board of Directors Read More »

May 1, 2017

ProSciento and Antaros Medical Present Scientific Data at the 2nd International NASH Biomarkers Workshop Read More »

February 15, 2017

mySugr Demonstrates Clinically Significant Impact on Diabetes Management for High Risk Population Read More »

September 14, 2016

ProSciento, Inc. and Antaros Medical Form Strategic Alliance to Incorporate Advanced Functional Imaging Techniques into Cardiometabolic Clinical Research Read More »

July 28, 2016

ProSciento and HighTide Biopharmaceutical Announce a Strategic Partnership Focused on the Development of New Therapies for Diabetes and NAFLD/NASH Read More »

June 10, 2016

ProSciento and LMC Diabetes Launch Strategic Partnership to Conduct Cross-Border Multi-Site Trials in Diabetes and Metabolism Read More »

June 9, 2016

 ProSciento and mySugr Collaborate to Advance Evidence-Based Clinical Validation of Diabetes mHealth Solutions Read More »

June 6, 2016

ProSciento Presents at the American Diabetes Association’s 76th Annual Scientific Sessions in New Orleans Read More »

April 5, 2016

ProSciento Assembles Team of 92 and Raises More Than $27,000 for American Diabetes Association’s Tour de Cure in San Diego Read More »

November 24, 2015

ProSciento Appoints Meryl Wiernik as Senior Director of CRO Services Read More »

November 9, 2015

Congratulations to Hanmi Pharmaceutical Co., Ltd. Read More »

October 29, 2015

ProSciento’s Corporate Team is Proud to Celebrate Its 11th Year Sponsoring JDRF’s ‘Walk to Cure Diabetes’ Event in San Diego Read More »

October 28, 2015

ProSciento and KineMed Collaborate to Pursue Circulating Biomarkers for NAFLD/NASH Clinical Research Read More »

October 28, 2015

ProSciento Announces Collaboration with Leading NAFLD/NASH Expert Dr. Rohit Loomba Read More »

October 28, 2015

ProSciento Unites Leading Experts in Biomarker Discovery and Clinical Research to Address the Medical Challenges of NAFLD/NASH Read More »

October 13, 2015

ProSciento Prepares to ‘Step Out’ Against Diabetes for an 11th Year, While Raising More Than $40,000 for the American Diabetes Association This Year Read More »

October 8, 2015

ProSciento Publishes White Paper Series Focused on the Current State of Diabetes, Obesity and NAFLD/NASH Clinical Research and Development Read More »

September 10, 2015

ProSciento Presents Diabetes, Obesity and NASH Research Study Results at the European Association for the Study of Diabetes Annual Meeting Read More »

June 4, 2015

ProSciento Announces Metabolism Focused ‘Discover & Translate’ Partnership with Gubra Read More »

May 30, 2015

ProSciento Presents at the American Diabetes Association’s 75th Annual Scientific Sessions in Boston Read More »

May 7, 2015

ProSciento Expands Clinical Development Leadership Team With Prominent Industry Experts Drs. Michael Trautmann and Gordon Brandt Read More »

April 15, 2015

ProSciento Assembles Team of 70 and Raises $35,000 for American Diabetes Association’s Tour de Cure in San Diego Read More »

January 22, 2015

New Textbook “Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development” Provides Critical Review of Current and Emerging Clinical Investigation Methods Read More »

November 18, 2014

ProSciento to Present at the Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease Read More »

September 5, 2013

ProSciento’s Recruitment Manager is Recipient of Insulindependence IN Champion Award Read More »


Please contact ProSciento’s corporate communications director at abby.devine@prosciento.com for any earlier archived news releases.